ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681637 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681637; 2) Community: the network communities that were significantly associated with the response to NSC 681637; 3) Molecule: the relationships between components within communities and NSC 681637; 4) MDR: the compounds that were significantly associated with the NSC 681637.

NSC Compound Enrichment Correlation
NSC 625603 Null 0.024108502230778 0.34506381
NSC 629971 Camptothecin Derivative 0.024108502230778 0.88951632
NSC 632840 Null 0.024108502230778 0.31426972
NSC 63839 Triacryloylhexahydro-s-triazine 0.024108502230778 0.149524
NSC 639521 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-2-(phenylmethyl)-, hydrochloride 0.024108502230778 0.22229263
NSC 642009 Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester 0.024108502230778 0.17340342
NSC 645018 1,4-bis(N-Cysteinyldiethylamino)-5,8-dihydroxy anthraquinon 0.024108502230778 0.79781573
NSC 657002 Null 0.024108502230778 0.078139958
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.024108502230778 0.65849322
NSC 664217 Null 0.024108502230778 0.15602454
Total:72  Current:36    [First] [Prev] [Next] [Last]